| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/19/2006 | CN1264548C Moutan bark and leech-containing capsule for lowering blood sugar and its preparation method |
| 07/19/2006 | CN1264547C Preparation of Chinese traditional medicine for treating coronary heart disease and angina as well as preparation method |
| 07/19/2006 | CN1264546C Prepared traditional medicine applied in tumor surgical operation, radiotheraphy and chemotherapy |
| 07/19/2006 | CN1264544C Nasal suppository for treating thinitis and its preparation method |
| 07/19/2006 | CN1264541C Method for producing agrimonia extract with improved activity against hepatitis Bvirus and pharmaceutical and food compositions containing said extract |
| 07/19/2006 | CN1264539C Recipe of drynaria rhizome and dipsacus root bone setting tablet |
| 07/19/2006 | CN1264537C Capsule for improving male impotence |
| 07/19/2006 | CN1264534C Application of Compound Danshen tablet in the preparation of medicine for preventing and treating senile dementia |
| 07/19/2006 | CN1264530C Freeze-dried 'Shenqifuzheng' powder injection preparing process |
| 07/19/2006 | CN1264529C Freeze-dried 'Shenqifuzheng' powder for injection preparing process |
| 07/19/2006 | CN1264528C Spot dispelling capsule and its preparation method |
| 07/19/2006 | CN1264526C Improved and stable extract from hypericum perforatuml, method for producing and uses as topical medicine |
| 07/19/2006 | CN1264522C Medicinal composition, its preparation method and its use |
| 07/19/2006 | CN1264519C Notoginseng total saponin amino acid transfusion liquid and its producing method |
| 07/19/2006 | CN1264516C Ligustrazine phosphate dripping pill and preparation thereof |
| 07/19/2006 | CN1264515C Externally applied Pioxican preparation and its preparation process |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264509C Precursor liposome preparation containing silybum marianum extract and its preparing process |
| 07/19/2006 | CN1264508C Arteannuin preparation for treating gynecopathy |
| 07/19/2006 | CN1264506C preparation method of pharmaceutical combination containing red sage root element |
| 07/19/2006 | CN1264505C Freeze dry powder injection of ketoprofen |
| 07/19/2006 | CN1264504C Composition and preparation method of soft capsule shell colloid emulsion |
| 07/19/2006 | CN1264503C Preparnig method for xiao Chaihu effervescent preparation and quality controlling method thereof |
| 07/19/2006 | CN1264502C Injection of still-freeze drying powder for restoring consciousness and new preparation method |
| 07/19/2006 | CN1264501C Process for preparing white arsenic nano particles |
| 07/19/2006 | CN1264500C Fat milk transfusion fluid for treating pulmonary heart disease and energy supplement and its producing method |
| 07/19/2006 | CN1264494C Method for preparing musk freeze-dried powder injection |
| 07/18/2006 | USRE39192 biocompatible wound healing agents comprising growth factors or drugs and fibrinogen |
| 07/18/2006 | US7078526 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 07/18/2006 | US7078431 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders |
| 07/18/2006 | US7078399 Antiulcer agents; antiinflammatory agents; therapy for ear infections |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | US7078394 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen as above and a progestogen equivalent to 90 mu g per day of norgestimate. |
| 07/18/2006 | US7078392 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 07/18/2006 | US7078388 DNA vaccines for farm animals, in particular bovines and porcines |
| 07/18/2006 | US7078221 Genetic engineered protein; bone disorders |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078072 Using hermetic sealed container; sublimation; uniform vapor deposition; controlling temperature, pressure |
| 07/18/2006 | US7078065 Plant extracts; adjustment pH with acid; prevention brain damage |
| 07/18/2006 | US7078060 Contacting an area with a solution of atomically disordered, nanocrystalline metal, metal alloy or metal compound; drug delivery; microbiocides; bactericides; fungicides; anticarcinogenic, -tumor and -inflammatory agents; viricides |
| 07/18/2006 | US7078058 Corticosteroid-containing pharmaceutical composition |
| 07/18/2006 | US7078057 Heating with carrier; mixtur eof fine and coarse particle sizes |
| 07/18/2006 | US7078056 Applying a hydrophilic foam substrate (isocyanate endcapped polyether polymer) and a hydrophilic agent to a portion of the skin surface in amount and location sufficient to reduce the severity of a bruise in the traumatized tissue |
| 07/18/2006 | US7078055 Method of attenuating swelling or inflammation |
| 07/18/2006 | US7078054 The capsule shell contains a migrateable component (other than glycerol) which is also present in the capsule filling. |
| 07/18/2006 | US7078053 Ibuprofen composition |
| 07/18/2006 | US7078052 Enhanced absorption and bioavailability |
| 07/18/2006 | US7078049 Oil in water emulsion; containing an haloalkynyl compound |
| 07/18/2006 | US7078047 Use of homopolymers and salts for moisturizing the skin, mucous membranes and/or keratin fibres, and/or as a moisturizer and/or emollient |
| 07/18/2006 | US7078046 Electrostatically-sprayable topical compositions having insulating external phase and conductive internal phase |
| 07/18/2006 | US7078045 Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 07/18/2006 | US7078032 Delivery of therapeutic biologicals from implantable tissue matrices |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | US7078016 Delivery of caffeine through an inhalation route |
| 07/18/2006 | US7078015 Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue |
| 07/18/2006 | US7077960 1,1,1,2-tetrafluoroethane containing organic impurities, is subjected to distillations, the second distillation being carried out at a pressure greater than that of first distillation, and hydrofluoroalkane purified is recovered |
| 07/18/2006 | US7077859 Apparatus and methods for variably controlled substance delivery from implanted prostheses |
| 07/18/2006 | CA2533038A1 Method of treatment for improved bioavailability |
| 07/18/2006 | CA2349088C Corn, callus and wart removing pads |
| 07/18/2006 | CA2313629C Method for transferring one or more active ingredients between different phase carriers |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/13/2006 | WO2006074358A1 Compositions and methods relating to novel compounds and targets thereof |
| 07/13/2006 | WO2006074204A2 Topical stabilized prostaglandin e compound dosage forms |
| 07/13/2006 | WO2006074185A2 Taste masking system for non-plasticizing drugs |
| 07/13/2006 | WO2006073950A2 Nanoparticles for protein drug delivery |
| 07/13/2006 | WO2006073729A1 Oral disintegrating dosage forms |
| 07/13/2006 | WO2006073520A2 Dual activating tdd |
| 07/13/2006 | WO2006073503A1 Therapeutic calcium phosphate particles for use in inhibiting expression of a gene |
| 07/13/2006 | WO2006073467A1 Anti-itch cloth for women |
| 07/13/2006 | WO2006073437A2 Photovoltaic thin-film cell produced from metallic blend using high-temperature printing |
| 07/13/2006 | WO2006073257A1 Syrup composition comprising dexibupropen as an active ingredient and method for the preparation thereof |
| 07/13/2006 | WO2006073164A1 Dialysis preparation |
| 07/13/2006 | WO2006073162A1 Method for improving storage stability of nadh or nadph or salt thereof |
| 07/13/2006 | WO2006073154A1 Medicinal composition and process for producing the same |
| 07/13/2006 | WO2006073061A1 Novel core-shell structure |
| 07/13/2006 | WO2006072948A2 Gastro-retentive diagnostic assemblies |
| 07/13/2006 | WO2006072888A2 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/13/2006 | WO2006072878A1 Oral dosage forms of sertraline having controlled particle size and processes for their preparation |
| 07/13/2006 | WO2006072872A1 Pharmaceutical formulation administratable orally in terms of a taste, consistency and a dosing |
| 07/13/2006 | WO2006072685A2 Method for preparing a solid pharmaceutical composition with prolonged and controlled release by high pressure treatment |
| 07/13/2006 | WO2006072577A1 Process for preparing granulates comprising amoxicillin |
| 07/13/2006 | WO2006072457A1 Particles containing phospholipids, production and use thereof as medicaments |
| 07/13/2006 | WO2006072440A1 Plastic bottle for oxaliplatin solution |
| 07/13/2006 | WO2006072424A1 PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF β-LACTAM ANTIBIOTICS IN COMBINATION WITH β-LACTAMASE INHIBITORS |
| 07/13/2006 | WO2006072367A1 Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release |
| 07/13/2006 | WO2006072329A2 Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion |
| 07/13/2006 | WO2006072252A1 Preparation for preventing or treating calcium deficiency conditions in mammals |
| 07/13/2006 | WO2006072201A1 Particle adjuvant for hifu therapy and the use thereof |
| 07/13/2006 | WO2006072200A1 Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof |
| 07/13/2006 | WO2006051549A3 Combination therapy associating preferably a ceramide with a cytotoxic drug |
| 07/13/2006 | WO2006050579A8 Solid particles from controlled destabilisation of microemulsions |
| 07/13/2006 | WO2006047362A3 Transdermal delivery systems |
| 07/13/2006 | WO2006040598A3 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
| 07/13/2006 | WO2006039532A3 Transdermal therapeutic system for parkinson’s disease |
| 07/13/2006 | WO2006037606A3 Wound dressing compositions, especially for delivery of protease inhibitors |
| 07/13/2006 | WO2006034397A3 Coating composition |
| 07/13/2006 | WO2006034080A3 Formulation comprising itraconazole |